Skip to main content

Advertisement

Figure 1 | BMC Infectious Diseases

Figure 1

From: Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: A comparative cohort analysis between Western India and United Kingdom

Figure 1

Time to progression to eGFR < 60 m/min/1.73 m 2 amongst those with baseline eGFR > 90 ml/min/1.73 m 2 . Legend: Time to development of eGFR < 60 ml/min/1.73 m2 as determined by MDRD amongst HIV positive individuals initiating Tenofovir with a baseline eGFR > 90 ml/min/1.73 m2 at IID, Pune (red) and Royal Free Hospital, UK (blue). The difference across the centres is statistically significant (p < 0.0001).

Back to article page